phase readout

NCT05528952: Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma

RECRUITINGupdated 20d ago

community read0 votes

Sponsor: Centre Hospitalier Universitaire de Besancon. Phase: PHASE2. Conditions: Hepatocellular Carcinoma

Data sources

last refreshed 11m ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?